Sponsor
University of Pittsburgh
Status
Active, not recruiting
NCT ID
NCT02842203
This observational study will evaluate circulating tumor DNA (ctDNA) as a prognostic marker and as a monitor of disease recurrence in stage III colorectal cancer (CRC).
Condition
Stage III Colorectal Cancer
Investigators
Robert Schoen, MD